NCT07187609 Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant
| NCT ID | NCT07187609 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Suez Canal University |
| Condition | Implant |
| Study Type | INTERVENTIONAL |
| Enrollment | 16 participants |
| Start Date | 2025-08-13 |
| Primary Completion | 2025-10-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 16 participants in total. It began in 2025-08-13 with a primary completion date of 2025-10-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate Clinical and radiographic effect of zinc incorporated bovine derived hydroxyapatite xenograft and bovine hydroxyapatite xenograft alone for immediately placed implant
Eligibility Criteria
Inclusion Criteria: * Adult(male or female) patients between the ages of 21 -50 years who requiring the replacement of one or more non-restorable teeth in the mandible which will be indicated for extraction. * Adequate bone dimensions at the implant site with ridge width of at least 6 mm, the availability of at least 3mm of sound subapical bone, the presence of an intact labial bone plate, and no evidance of periapical infection on cone beam computed tomography or clinically * The peri-implant gaps larger than 1.5 mm will be included. * All patients will be physically healthy with no medical history of any systemic disease. Exclusion Criteria: * Smokers. * Patients with para functional habits such as bruxism and clenching * Poorly controlled systemic diseases which preclude local anesthesia or surgical procedures * Patients undergoing chemotherapy or radiotherapy and immuno-compromised patients. * Pregnant /lactating women. * Patients that are allergic to zinc * Patients on antibiotic therapy in the pervious 6 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07187609 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 50 Years, studying Implant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07187609 currently recruiting?
Yes, NCT07187609 is actively recruiting participants. Contact the research team at pgs.230046@dent.suez.edu.eg for enrollment information.
Where is the NCT07187609 trial being conducted?
This trial is being conducted at Suez, Egypt.
Who is sponsoring the NCT07187609 clinical trial?
NCT07187609 is sponsored by Suez Canal University. The trial plans to enroll 16 participants.